CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		3 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Operating activities:
Net income (loss)		$ (5,793)	$ 4,726
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock-based compensation expense		3,430	2,442
Amortization of intangible assets		3,847	4,487
Depreciation and amortization		391	343
Amortization of investment premiums & other		(1,398)	13
Accretion and amortization on debt securities		1,970	1,844
Net changes in estimated fair value of acquisition-related contingent consideration		136	330
Deferred taxes		(1,708)	(3,459)
Changes in assets and liabilities, net of acquisitions:
Accounts receivable		(2,771)	58
Contract assets		(511)	(5,507)
Other assets		(3,192)	(154)
Accounts payable		2,520	980
Accrued payroll and related taxes		(3,704)	(4,174)
Income taxes payable	[1]	(4,254)	5,149
Deferred revenue		857	(1,521)
Restructuring accrual		0	(651)
Other liabilities	[1]	717	354
Net cash provided by (used in) operating activities		(9,463)	5,260
Investing activities:
Purchases of investments		(14,991)	0
Sales and maturities of investments		33,121	18,750
Purchases of property and equipment, net		(241)	(154)
Net cash provided by (used in) investing activities		17,889	18,596
Financing activities:
Proceeds from the issuance of equity plan common stock		856	662
Payment of acquisition-related contingent consideration		(4,641)	0
Proceeds from other borrowings		707	0
Principal payments on other borrowings		(36)	(36)
Net cash provided by (used in) financing activities		(3,114)	626
Foreign currency effect on cash and cash equivalents		313	574
Net increase in cash and cash equivalents		5,625	25,056
Cash and cash equivalents at beginning of period		58,913	32,059
Cash and cash equivalents at end of period		64,538	57,115
Supplemental disclosures of cash flow information:
Issuance of common stock for acquisition-related contingent consideration		3,471	0
Cash paid for income taxes		7,838	213
Supplemental disclosures of non-cash investing and financing activities:
Unrealized holding gain on available for sale investments		$ 102	$ 352

[1] December 31, 2022 condensed consolidated statement of cash flows reflects reclassifications to conform to the current year presentation.